Role of End Binding Protein-1 in endothelial permeability response to barrier-disruptive and barrier-enhancing agonists

Cell Signal. 2017 Jan:29:1-11. doi: 10.1016/j.cellsig.2016.09.005. Epub 2016 Sep 23.

Abstract

Rapid changes in microtubule (MT) polymerization dynamics affect regional activity of small GTPases RhoA and Rac1, which play a key role in the regulation of actin cytoskeleton and endothelial cell (EC) permeability. This study tested the role of End Binding Protein-1 (EB1) in the mechanisms of increased and decreased EC permeability caused by thrombin and hepatocyte growth factor (HGF) and mediated by RhoA and Rac1 GTPases, respectively. Stimulation of human lung EC with thrombin inhibited peripheral MT growth, which was monitored by morphological and biochemical evaluation of peripheral MT and the levels of stabilized MT. In contrast, stimulation of EC with HGF promoted peripheral MT growth and protrusion of EB1-positive MT plus ends to the EC peripheral submembrane area. EB1 knockdown by small interfering RNA did not affect partial MT depolymerization, activation of Rho signaling, and permeability response to thrombin, but suppressed the HGF-induced endothelial barrier enhancement. EB1 knockdown suppressed HGF-induced activation of Rac1 and Rac1 cytoskeletal effectors cortactin and PAK1, impaired HGF-induced assembly of cortical cytoskeleton regulatory complex (WAVE-p21Arc-IQGAP1), and blocked HGF-induced enhancement of peripheral actin cytoskeleton and VE-cadherin-positive adherens junctions. Altogether, these data demonstrate a role for EB1 in coordination of MT-dependent barrier enhancement response to HGF, but show no involvement of EB1 in acute increase of EC permeability caused by the barrier disruptive agonist. The results suggest that increased peripheral EB1 distribution is a critical component of the Rac1-mediated pathway and peripheral cytoskeletal remodeling essential for agonist-induced EC barrier enhancement.

Keywords: Cytoskeleton; GTPase; Microtubule dynamics; Permeability; Pulmonary endothelium.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / metabolism
  • Actins / metabolism
  • Adherens Junctions / drug effects
  • Adherens Junctions / metabolism
  • Cell Line
  • Cell Membrane Permeability* / drug effects
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism
  • Endothelial Cells / cytology*
  • Endothelial Cells / metabolism*
  • Gene Knockdown Techniques
  • Hepatocyte Growth Factor / pharmacology
  • Humans
  • Microtubule-Associated Proteins / metabolism*
  • Microtubules / drug effects
  • Microtubules / metabolism
  • Signal Transduction / drug effects
  • Thrombin / pharmacology
  • Wiskott-Aldrich Syndrome Protein Family / metabolism
  • rac GTP-Binding Proteins / metabolism
  • ras GTPase-Activating Proteins / metabolism
  • rho GTP-Binding Proteins / metabolism

Substances

  • Actins
  • Cyclin-Dependent Kinase Inhibitor p21
  • HGF protein, human
  • IQ motif containing GTPase activating protein 1
  • MAPRE1 protein, human
  • Microtubule-Associated Proteins
  • Wiskott-Aldrich Syndrome Protein Family
  • ras GTPase-Activating Proteins
  • Hepatocyte Growth Factor
  • Thrombin
  • rac GTP-Binding Proteins
  • rho GTP-Binding Proteins